Greenberg Traurig Hosts Portugal Delegation to Foster Collaboration in Medtech, Life Sciences, and Technology

Share Article

Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group held a Portugal Stakeholder Breakfast that brought together a delegation of government leaders and trade representatives from Portugal with relevant stakeholders in the Boston area to discuss collaboration between Portugal and Boston in the medtech, life sciences, and technology sectors.

Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group held a Portugal Stakeholder Breakfast that brought together a delegation of government leaders and trade representatives from Portugal with relevant stakeholders in the Boston area to discuss collaboration between Portugal and Boston in the medtech, life sciences, and technology sectors. The event was held Feb. 21 in the firm’s Boston office.

The breakfast aimed to foster cooperation and create synergies between U.S. and Portuguese entrepreneurs, companies, investors, and research institutions. Participants engaged with Portugal stakeholders in the technology and life sciences sectors to explore opportunities for investment, new business development, and R&D collaboration.

Featured speakers included Fezas Vital, Portugal Ambassador to the U.S. Domingos, and Robert A. Sherman, former U.S. Ambassador to Portugal and senior counsel in Greenberg Traurig’s Boston office. David J. Dykeman, patent attorney, co-chair of the global Life Sciences & Medical Technology Group and co-managing shareholder of the firm’s Boston office, gave introductory remarks.

“The U.S. and Portugal continue to work together to find ways to expand and deepen two-way trade and investment. Portugal’s continued drive to modernize and diversify its economy and Boston’s position as a hub for health care and tech innovation create a strong platform for collaboration and business opportunities. We look forward to further developing the deep relationship between the Boston and Portugal,” said Sherman.

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig’s Boston Office: Established in 1999, Greenberg Traurig’s Boston office is home to over 70 attorneys practicing in the areas of bankruptcy, business aviation, corporate, emerging technology, energy, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, and real estate. An important contributor to the firm's international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of legal experience and hands-on knowledge of the local business community, supported by the firm's vast network of global resources.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2,200 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo-Martinez
@GT_Law
Follow >
Visit website